SCOTTSDALE, ARIZONA--(Marketwire - January 09, 2008) - Holmes Biopharma, Inc. (OTCBB: HLMB) announces the signing of a $1.6 million contract with a major biotech company for conducting a Phase 1 trial at the company’s facility in Omaha, Nebraska. This is the largest single contract signed to date, and brings the total of committed contracts in 2007 to $13 million.
